Psomagen has announced the expansion of its single-cell capabilities by integrating the LevitasBio LeviCell EOS system into its service. This cutting-edge technology is a solution of choice to enhance the gentle purification process before single-cell sequencing, supporting clients’ needs for consistent, high-quality data. Alongside this, Psomagen has also incorporated Parse Biosciences into its single-cell portfolio, further strengthening its commitment to advanced cellular research.

From their press release:
Other recent additions to Psomagen’s single-cell capabilities include the LeviCell EOS from LevitasBio. This system provides a gentle purification workflow prior to single-cell sequencing. This step is ideal for removing dead cells following cryopreservation, removing debris during nuclei isolation, and removing ambient RNA or other unwanted signal from a cell suspension. Cleaner samples yield cleaner data and less wasted sequencing costs.  

“Sample quality is paramount to generating high quality, reproducible data,” says Linda Orzolek. “Psomagen recognizes the importance of offering a variety of options for our clients to ensure we meet their needs and the needs of their samples. If you come to us with a problem or a goal, we want to have not just a solution, but the RIGHT solution for your specific research, and that means expanding our services across multiple platforms and offering clients the flexibility that they need.”

About Psomagen

Psomagen, Inc., formerly Macrogen Corp, is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the clinical and academic markets. With both CLIA-certified and CAP-accredited facilities, their team delivers only the highest-quality integrative multi-omics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.